Literature DB >> 27759811

Ketogenic diet for epilepsy treatment.

Letícia Pereira de Brito Sampaio1.   

Abstract

The ketogenic diet (KD), a high-fat, low-carbohydrate, and adequate-protein diet is an established, effective nonpharmacologic treatment option for intractable childhood epilepsy. The KD was developed in 1921 and even though it has been increasingly used worldwide in the past decade, many neurologists are not familiar with this therapeutic approach. In the past few years, alternative and more flexible KD variants have been developed to make the treatment easier and more palatable while reducing side effects and making it available to larger group of refractory epilepsy patients. This review summarizes the history of the KD and the principles and efficacy of the classic ketogenic diet, medium-chain triglyceride(s) (MCT) ketogenic diet, modified Atkins diet, and low glycemic index treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27759811     DOI: 10.1590/0004-282X20160116

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  19 in total

Review 1.  Antiaging diets: Separating fact from fiction.

Authors:  Mitchell B Lee; Cristal M Hill; Alessandro Bitto; Matt Kaeberlein
Journal:  Science       Date:  2021-11-19       Impact factor: 63.714

Review 2.  Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration.

Authors:  Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2018-09-21       Impact factor: 1.967

3.  Suppression of insulin feedback enhances the efficacy of PI3K inhibitors.

Authors:  Benjamin D Hopkins; Chantal Pauli; Xing Du; Diana G Wang; Xiang Li; David Wu; Solomon C Amadiume; Marcus D Goncalves; Cindy Hodakoski; Mark R Lundquist; Rohan Bareja; Yan Ma; Emily M Harris; Andrea Sboner; Himisha Beltran; Mark A Rubin; Siddhartha Mukherjee; Lewis C Cantley
Journal:  Nature       Date:  2018-07-04       Impact factor: 49.962

Review 4.  Ketogenic Diet and Epilepsy.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Nutrients       Date:  2019-10-18       Impact factor: 5.717

Review 5.  Molecular basis of Leigh syndrome: a current look.

Authors:  Manuela Schubert Baldo; Laura Vilarinho
Journal:  Orphanet J Rare Dis       Date:  2020-01-29       Impact factor: 4.123

Review 6.  Keto microbiota: A powerful contributor to host disease recovery.

Authors:  Amanda Cabrera-Mulero; Alberto Tinahones; Borja Bandera; Isabel Moreno-Indias; Manuel Macías-González; Francisco J Tinahones
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 7.  The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations.

Authors:  Thomas M Barber; Petra Hanson; Stefan Kabisch; Andreas F H Pfeiffer; Martin O Weickert
Journal:  Nutrients       Date:  2021-04-03       Impact factor: 5.717

8.  What should we ask patients with epilepsy on telemedicine during the COVID-19 crisis? A checklist for clinicians.

Authors:  Naoto Kuroda
Journal:  Epilepsy Behav       Date:  2020-05-25       Impact factor: 2.937

9.  Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease.

Authors:  Chika V Anekwe; Poongodi Chandrasekaran; Fatima C Stanford
Journal:  Cureus       Date:  2020-01-08

Review 10.  The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn's Disease.

Authors:  Eliza Starz; Karolina Wzorek; Marcin Folwarski; Karolina Kaźmierczak-Siedlecka; Laura Stachowska; Katarzyna Przewłócka; Ewa Stachowska; Karolina Skonieczna-Żydecka
Journal:  Nutrients       Date:  2021-06-22       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.